Search all medical codes

Chromosome analysis, amniotic fluid or chorionic villus, count 15 cells, 1 karyotype, with banding

CPT4 code

Name of the Procedure:

Chromosome Analysis, Amniotic Fluid or Chorionic Villus, Count 15 Cells, 1 Karyotype, with Banding

  • Common Name: Karyotyping
  • Medical Term: Chromosomal Analysis with G-banding

Summary

Chromosome analysis of amniotic fluid or chorionic villus involves collecting a sample from a pregnant woman to examine the baby's chromosomes. This procedure helps identify genetic abnormalities or conditions.

Purpose

  • Medical Condition Addressed: Genetic disorders and chromosomal abnormalities.
  • Goals: To identify abnormalities such as Down syndrome, Patau syndrome, and other chromosomal anomalies.

Indications

  • Pregnancy at advanced maternal age (≥35 years).
  • Family history of genetic disorders.
  • Abnormal results from non-invasive prenatal tests.
  • Previous child or pregnancy with chromosomal abnormalities.
  • Ultrasound findings suggestive of genetic syndromes.

Preparation

  • Pre-procedure ultrasound to locate the fetus and amniotic fluid.
  • No specific fasting or medication adjustments are typically needed unless advised by the healthcare provider.
  • Detailed counseling about risks and benefits.

Procedure Description

  1. Amniotic Fluid Sampling (Amniocentesis):
    • A needle is inserted through the abdomen into the uterus to draw a small sample of amniotic fluid.
  2. Chorionic Villus Sampling (CVS):
    • A small tissue sample from the placenta is obtained, either transcervically (through the cervix) or transabdominally (through the abdomen).
  3. Laboratory Analysis:
    • The sample cells are cultured.
    • Chromosomes are stained using a technique called G-banding.
    • Under a microscope, 15 cells are counted and analyzed for karyotypic abnormalities.

Duration

  • The sampling procedure takes approximately 30 minutes.
  • Laboratory analysis and results can take 1-2 weeks.

Setting

  • Performed in a hospital or specialized outpatient clinic equipped with ultrasound and laboratory facilities.

Personnel

  • Obstetrician or maternal-fetal medicine specialist.
  • Trained nurse or medical technician.
  • Laboratory geneticist or cytogeneticist.

Risks and Complications

  • Common Risks: Mild discomfort or cramping, minor bleeding, leakage of amniotic fluid.
  • Rare Risks: Infection, preterm labor, miscarriage.

Benefits

  • Accurate diagnosis of chromosomal abnormalities.
  • Enables informed decision-making regarding the pregnancy.
  • Early detection of genetic conditions allows for better management and planning.

Recovery

  • Rest and avoid strenuous activities for 24 hours post-procedure.
  • Follow-up ultrasound to ensure fetal well-being.
  • Normal activities can usually resume the following day unless advised otherwise.

Alternatives

  • Non-invasive prenatal testing (NIPT) with cell-free fetal DNA.
  • Ultrasonography for structural anomalies.
  • Each alternative varies in accuracy and risk, with some offering less diagnostic certainty but also lower risk.

Patient Experience

  • Patients may feel anxious during and after the procedure; emotional support is important.
  • Pain is generally minimal but can be managed with over-the-counter pain relief if necessary.
  • Patients should report any severe pain, fever, or heavy bleeding to their healthcare provider immediately.

Medical Policies and Guidelines for Chromosome analysis, amniotic fluid or chorionic villus, count 15 cells, 1 karyotype, with banding

Related policies from health plans

Similar Codes